News

Enzo Life Sciences Launches New PLAQPRO™ Lp-PLA2 Assay to Measure Cardiac Risk

Enzo Life Sciences is proud to introduce our new assay, PLAQPRO™ Lp-PLA2 Assay, measuring the activity of Lp-PLA2 in vitro.  Lp-PLA2 is produced by inflammatory cells and circulates primarily bound to LDL. The oxidization of LDL is an early key event in the pathogenesis of atherosclerosis. Increased levels of Lp-PLA2 have been found in atherosclerotic plaques and rupture lesions. The PLAQPRO™ Lp-PLA2 Assay is a colorimetric readout assay that measures the activity of Lp-PLA2 in serum samples. Our assay represents a cost-efficient alternative to…

Enzo Life Sciences Launches New Immunoassay to Detect Low Levels of IL-6

Enzo Life Sciences is proud to introduce our newest immunoassay, IL-6 (human), high sensitivity ELISA kit, the most sensitive IL-6 ELISA on the market. Enzo’s new kit is able to detect IL-6 levels down to 0.057 pg/mL. In addition, our kit offers detection in 3 hours, with liquid color-coded reagents that reduce the possibility for error. From forty years of manufacturing, Enzo’s immunoassays offer high precision, accuracy, sensitivity, and specificity. IL-6 is a cytokine critical to the regulation of the…

Microbial Testing Without the Burden: New EZ-Fit™ Filtration Units from MilliporeSigma

MilliporeSigma has expanded its portfolio of EZ-Fit™ filtration units, ready-to-use, disposable filtration devices for bioburden testing. The new EZ-Fit™ filtration units come with a wide range of membrane sizes to suit all applications, and a new patented drain design to accelerate processing of turbid and hard-to-filter matrices. The full portfolio, including the new units, conforms to international standards (USP/EP) and water testing regulations, and can be used for filtration of liquid samples including water, raw materials, in-process samples and final…

CASSS and Biophysics Working Group Aim to Increase Scientific Dialogue About Biologics

CASSS has partnered with the Biophysics Working Group to support its mission to bring together scientists from across public and private sectors to address challenges in biologics research and development. The goals of the Biophysics Working Group are to provide guidance and best practices, support innovation, advance transformative ideas, and generally enhance the overall scientific dialogue through contributions in various publications and CASSS conferences around the world. This group also aligns with CASSS’s purpose to enable a global community of…

Finesse® Solutions Launches SmartVessel™, a Single-Use 3L Bioreactor for Cell Culture and Fermentation

Finesse Solutions, Inc., a manufacturer of measurement and control solutions for life sciences process applications, announced the launch of SmartVessel, a single-use 3-liter bioreactor vessel. The SmartVessel features integrated single-use sensors for cell culture applications of mammalian, stem, insect, and plant cells. The SmartVessel also has separate electrochemical sensor ports for fermentation and bio-fuels applications.   All wetted materials of the SmartVessel are USP class VI-compliant, animal derived component-free, latex-free, BPA-free, and phthalate-free. This stirred tank bioreactor allows working volumes ranging…

Lonza and Forty Seven, Inc., Announce Strategic Manufacturing Agreement for Immuno-Oncology Therapeutic Antibody Pipeline

Lonza, a global leader in biological manufacturing, and Forty Seven, Inc., a clinical-stage immuno-oncology company, announced today a strategic manufacturing agreement for the clinical supply of Forty Seven’s therapeutic antibodies. Under the agreement Lonza will manufacture material at its Slough (UK) facility for Forty Seven’s ongoing and future clinical trials. Forty Seven is committed to the advancement of immuno-oncology through the engagement of new and complementary phagocytic pathways that enhance anti-tumor efficacy and selectivity. Its lead molecule, Hu5F9-G4, is a…

PROVEO Partnership Expands with Addition of Cerbios-Pharma and Oncotec Pharma for the Manufacture of ADCs

CMC Biologics A/S, a global leader in clinical and commercial manufacturing of monoclonal antibodies and other therapeutic proteins, and IDT Biologika GmbH, a privately-held life-science company with a 95 year history of expertise in research, development and manufacture of biologics for human and animal health, announced the addition of Cerbios-Pharma SA (“Cerbios”) and Oncotec Pharma Produktion GmbH (“Oncotec“) to PROVEO, their strategic collaboration for providing a complete and efficient solution to the market for the process development and manufacture of…

MilliporeSigma Introduces Mobius® Power MIX 2000 for Difficult-to-Mix Biopharm Ingredients

MilliporeSigma’s Mobius® Power MIX 2000 single-use mixing system is engineered with advanced technology to effectively handle difficult-to-mix buffers, culture media powders and other pharmaceutical ingredients. The Mobius® Power MIX achieves a strong vortex using an impeller design and motor based on magnetically-coupled NovAseptic® technology, a proven mixing technology in stainless steel tanks. The Power MIX 2000 provides accessible, sterile zero deadleg sampling directly from the mixing container. A Probe Port allows for insertion of either a reusable probe for non-aseptic processes or a…

BioProcess International Announces Winners of the 2016 BioProcess International Awards

BioProcess International magazine today announced the winners for the 2016 BioProcess International Awards. The awards celebrate the outstanding achievements, collaborations, business strategies, social corporate responsibility and technology applications that will allow the industry to deliver better, more effective treatments to a global patient base. Winners and finalists were honored and recognized by their peers during a very entertaining and exciting awards dinner and ceremony Wednesday evening, 5 October at the Boston Convention and Exhibition Center in Boston, MA. “The BioProcess…

Bio-Rad Launches Nuvia™ IMAC Affinity Resin for Process Scale Purifications at Bioprocess International Conference and Exhibition 2016

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) released Nuvia™ IMAC Resin, an immobilized metal affinity chromatography resin optimized for use from lab scale through pilot studies to process-scale manufacturing, at the 2016 Bioprocess International Conference and Exhibition, Boston, Oct. 4–7. Bio-Rad (Booth #1129) will also exhibit a host of customizable workflows designed to simplify and speed up drug discovery and development, including automated multicolumn protein purification, host cell protein and host cell DNA analysis, and CRISPR/Cas9 transfection and monitoring. A…